CRISPR Therapeutics raised €35M in a Series B round in Jun 2016. The company is based in Basel, Switzerland. Investors in the round: Clough Capital Partners, Franklin Templeton Investments, New Leaf Venture Partners and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €35M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
